IPO registrations (S-1, F-1) · Registrants
AXE COMPUTE INC.
- SEC CIK
- 1446159 · filings on EDGAR ↗
- Name on the registration
- Predictive Oncology Inc.
- Former names
- Axe Compute Inc. (2025–2026); Predictive Oncology Inc. (2019–2025); Precision Therapeutics Inc. (2018–2019); Skyline Medical Inc. (2013–2018); BioDrain Medical, Inc. (2008–2013)
- Registration
- Form S-1, first filed 2008-11-12, last 2025-07-18; 12 initial registrations, 31 amendments
- Outcome
- Final prospectus filed 2015-08-27; declared effective 2009-10-19; withdrawal requested 2015-02-09
- Industry (SIC)
- Finance Services 6199
- Incorporated in
- DE
- Business address
- 801 BRICKELL AVENUE, SUITE 510, Miami, FL 33131
- EIN
- 33-1007393
- Ticker
- AGPU (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- AXE COMPUTE INC. on the corporate pages
Offering terms
- Final price
- $9.00 per share (424B4 filed 2015-08-27)
- Shares sold
- 1,666,667
- Gross proceeds
- $15,000,003 before underwriting discounts and any over-allotment option
- Listing
- OTCQB under the symbol SKLN.QB
- Lead underwriters
- Dawson James
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: SKYLINE MEDICAL INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: AXE COMPUTE INC EXACT (EIN (EXACT))
- Form D issuer: Predictive Oncology Inc. EXACT (CIK (EXACT))
- SEC filer: Axe Compute Inc. EXACT (CIK (EXACT))
- Person page: Arnon I Dreyfuss Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: J Melville Engle Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other))
- Person page: Kevin R Davidson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
Filings 77
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-11-12 | S-1 | S-1 (registration) | BioDrain Medical, Inc. | 0000897101-08-002272 ↗ |
| 2009-01-12 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-001463 ↗ |
| 2009-02-12 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-007511 ↗ |
| 2009-04-06 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-019121 ↗ |
| 2009-05-14 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-026696 ↗ |
| 2009-07-01 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-035506 ↗ |
| 2009-07-31 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-039810 ↗ |
| 2009-08-12 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-042287 ↗ |
| 2009-08-20 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-044939 ↗ |
| 2009-09-04 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-047217 ↗ |
| 2009-09-30 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-050866 ↗ |
| 2009-10-08 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-09-052132 ↗ |
| 2009-10-19 | EFFECT | EFFECT (declared effective) | BioDrain Medical, Inc. | 9999999995-09-002884 ↗ |
| 2010-05-07 | EFFECT | EFFECT (declared effective) | BioDrain Medical, Inc. | 9999999995-10-001420 ↗ |
| 2012-01-24 | S-1 | S-1 (registration) | BioDrain Medical, Inc. | 0001144204-12-003653 ↗ |
| 2012-01-30 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-12-004604 ↗ |
| 2012-11-05 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-12-059305 ↗ |
| 2013-02-08 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-13-006917 ↗ |
| 2013-04-24 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-13-023591 ↗ |
| 2013-05-10 | S-1/A | S-1/A (amendment) | BioDrain Medical, Inc. | 0001144204-13-027900 ↗ |
| 2013-05-14 | EFFECT | EFFECT (declared effective) | BioDrain Medical, Inc. | 9999999995-13-001513 ↗ |
| 2014-08-25 | S-1 | S-1 (registration) | Skyline Medical Inc. | 0001144204-14-052331 ↗ |
| 2014-09-08 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001144204-14-054665 ↗ |
| 2014-09-08 | EFFECT | EFFECT (declared effective) | Skyline Medical Inc. | 9999999995-14-002696 ↗ |
| 2014-09-26 | S-1 | S-1 (registration) | Skyline Medical Inc. | 0001144204-14-058012 ↗ |
| 2014-11-26 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001144204-14-071006 ↗ |
| 2014-12-16 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001144204-14-074287 ↗ |
| 2015-01-08 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001144204-15-001357 ↗ |
| 2015-02-02 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001144204-15-005336 ↗ |
| 2015-02-09 | RW | RW (withdrawal request) | Skyline Medical Inc. | 0001144204-15-006869 ↗ |
| 2015-07-20 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001214659-15-005449 ↗ |
| 2015-07-29 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001214659-15-005620 ↗ |
| 2015-07-31 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001214659-15-005735 ↗ |
| 2015-08-10 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001214659-15-005946 ↗ |
| 2015-08-20 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001214659-15-006214 ↗ |
| 2015-08-25 | EFFECT | EFFECT (declared effective) | Skyline Medical Inc. | 9999999995-15-002369 ↗ |
| 2015-08-27 | 424B4 | 424B4 (final prospectus) | Skyline Medical Inc. | 0001214659-15-006348 ↗ |
| 2016-02-12 | EFFECT | EFFECT (declared effective) | Skyline Medical Inc. | 9999999995-16-003766 ↗ |
| 2016-03-21 | RW | RW (withdrawal request) | Skyline Medical Inc. | 0001171843-16-008695 ↗ |
| 2016-04-05 | EFFECT | EFFECT (declared effective) | Skyline Medical Inc. | 9999999995-16-004143 ↗ |
| 2016-10-04 | EFFECT | EFFECT (declared effective) | Skyline Medical Inc. | 9999999995-16-005879 ↗ |
| 2016-12-09 | S-1 | S-1 (registration) | Skyline Medical Inc. | 0001171843-16-013569 ↗ |
| 2017-01-10 | S-1/A | S-1/A (amendment) | Skyline Medical Inc. | 0001171843-17-000178 ↗ |
| 2017-01-12 | EFFECT | EFFECT (declared effective) | Skyline Medical Inc. | 9999999995-17-000089 ↗ |
| 2017-01-13 | 424B4 | 424B4 (final prospectus) | Skyline Medical Inc. | 0001171843-17-000227 ↗ |
| 2017-05-08 | EFFECT | EFFECT (declared effective) | Skyline Medical Inc. | 9999999995-17-001217 ↗ |
| 2017-12-21 | EFFECT | EFFECT (declared effective) | Skyline Medical Inc. | 9999999995-17-003294 ↗ |
| 2019-10-30 | S-1 | S-1 (registration) | Predictive Oncology Inc. | 0001171843-19-006929 ↗ |
| 2019-11-15 | S-1/A | S-1/A (amendment) | Predictive Oncology Inc. | 0001171843-19-007593 ↗ |
| 2019-11-19 | S-1/A | S-1/A (amendment) | Predictive Oncology Inc. | 0001171843-19-007659 ↗ |
| 2019-11-19 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-19-002612 ↗ |
| 2019-12-20 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-19-002885 ↗ |
| 2019-12-20 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-19-002892 ↗ |
| 2020-04-15 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-20-000760 ↗ |
| 2020-06-16 | S-1 | S-1 (registration) | Predictive Oncology Inc. | 0001171843-20-004383 ↗ |
| 2020-06-23 | S-1/A | S-1/A (amendment) | Predictive Oncology Inc. | 0001171843-20-004497 ↗ |
| 2020-06-24 | S-1 | S-1 (registration) | Predictive Oncology Inc. | 0001171843-20-004536 ↗ |
| 2020-06-24 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-20-001530 ↗ |
| 2020-07-06 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-20-001656 ↗ |
| 2020-07-21 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-20-001878 ↗ |
| 2020-09-14 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-20-002431 ↗ |
| 2021-01-29 | S-1 | S-1 (registration) | Predictive Oncology Inc. | 0001171843-21-000621 ↗ |
| 2021-01-29 | S-1 | S-1 (registration) | Predictive Oncology Inc. | 0001171843-21-000622 ↗ |
| 2021-02-05 | S-1/A | S-1/A (amendment) | Predictive Oncology Inc. | 0001171843-21-000779 ↗ |
| 2021-02-09 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-21-000533 ↗ |
| 2021-02-09 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-21-000534 ↗ |
| 2021-03-23 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-21-001097 ↗ |
| 2021-05-05 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-21-001807 ↗ |
| 2022-09-30 | S-1 | S-1 (registration) | Predictive Oncology Inc. | 0001171843-22-006337 ↗ |
| 2022-10-13 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-22-003039 ↗ |
| 2024-05-21 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-24-001603 ↗ |
| 2024-08-23 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-24-002618 ↗ |
| 2025-07-18 | S-1 | S-1 (registration) | Predictive Oncology Inc. | 0001171843-25-004561 ↗ |
| 2025-07-28 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-25-002376 ↗ |
| 2025-11-21 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-25-003348 ↗ |
| 2025-11-25 | EFFECT | EFFECT (declared effective) | Predictive Oncology Inc. | 9999999995-25-003388 ↗ |
| 2026-07-27 | EFFECT | EFFECT (declared effective) | Axe Compute Inc. | 9999999995-26-002459 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-08-20 | S-1/A | registration statement | $9.75 | 1,666,667 | $16,250,003 | OTCQB SKLN.QB | 1 | primary document; price line, shares headline, proceeds computed, cover names 1 | document ↗ | |
| 2015-08-27 | 424B4 | final prospectus | $9.00 | 1,666,667 | $15,000,003 | OTCQB SKLN.QB | 1 | primary document; price table, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Shuler Alan | Officer | Corporate Secretary; Secretary | 3 | 2009–2011 | |
| Davidson Kevin R. | Director,Officer | CEO, President, and CFO; President, CEO and CFO | 2 | 2009–2011 | person page Fuzzy |
| Doerfert Kirsten | Officer | VP of Sales and Marketing | 1 | 2009 | |
| Ruwe Chad A. | Director; Director,Officer | Chief Operating Officer | 4 | 2009–2012 | |
| Gadbaw Lawrence W. | Director | 2 | 2009–2011 | ||
| Morawetz Peter L. | Director | 2 | 2009–2011 | ||
| DAUWALTER JAMES E | Director | 2 | 2009–2011 | ||
| McGoldrick Thomas J. | Director | 27 | 2009–2020 | ||
| Reding Andrew P. | Director | 30 | 2009–2020 | ||
| GALITZ JEFFREY | Director | 1 | 2012 | ||
| Kornberg Joshua | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwner | CEO and President; Interim CEO, President & CFO; President and CEO | 30 | 2012–2016 | |
| Herschkowitz Samuel | TenPercentOwner | 39 | 2012–2014 | ||
| SOK Partners LLC | TenPercentOwner | 9 | 2012–2015 | ||
| EMOLA ALBERT | Director | 1 | 2012 | ||
| POSA PHILIP JR | Other | 1 | 2012 | ||
| Caron Partners LP | Other; TenPercentOwner | 3 | 2012–2013 | ||
| Koenigsberger Ricardo | Director | 7 | 2012–2015 | ||
| JOHNSON DAVID O. | Officer | Chief Operating Officer | 9 | 2012–2017 | |
| MYERS ROBERT L | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 19 | 2012–2023 | |
| Schwartz Carl I. | Director; Director,Officer; Director,Officer,TenPercentOwner; Other; TenPercentOwner | Chief Executive Officer | 38 | 2013–2021 | |
| DREYFUSS ARNON I | Director | 10 | 2013–2014 | person page Fuzzy | |
| MANCUSO FRANK G /FA/ | Director | 8 | 2013–2015 | ||
| Taney Richard | Director | 1 | 2016 | ||
| ENGLE J MELVILLE | Director; Director,Officer; Other | CEO and Chairman | 28 | 2016–2022 | person page Fuzzy |
| KROCHUK TIMOTHY A | Director | 15 | 2016–2019 | ||
| GABRIEL RICHARD L | Director | 29 | 2016–2021 | ||
| Vardzel Gerald J Jr | Director | 3 | 2019–2020 | ||
| PRIOR PAMELA S | Director | 2 | 2020 | ||
| HANDLEY DANIEL E | Director | 25 | 2020–2026 | ||
| CHUNG-WELCH NANCY | Director | 17 | 2020–2025 | ||
| Nuzum Charles Lee Sr | Director | 22 | 2020–2026 | ||
| ST. CLAIR GREGORY SR | Director | 19 | 2020–2026 | ||
| Jenkins Christina Lee MD | Director | 7 | 2021–2022 | ||
| Vennare Raymond F | Director; Director,Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 12 | 2021–2026 | |
| Smith David Stewart | Director | 4 | 2022–2023 | ||
| Hawryluk Matthew | Director | 10 | 2022–2026 | ||
| Bush Pamela | Officer | Chief Business Officer | 1 | 2023 | |
| Rao Veena | Director | 7 | 2023–2026 | ||
| Blacher Joshua | Officer | Co-Chief Financial Officer; Interim CFO | 3 | 2025–2026 | |
| Matthews Shawn | Director | 2 | 2025–2026 | ||
| McLaughlin Thomas Louis | Officer | Chief Investment Officer | 1 | 2025 | |
| MIGLINO CHRISTOPHER | Director,Officer | CEO and Director | 2 | 2026 | |
| Okamoto Kyle Robert | Officer | President | 2 | 2026 | |
| Yaukey-Witter Jeremy Reese | Officer | Co-Chief Financial Officer | 2 | 2026 | |
| Zhu Theodore | Director | 5 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-10-22 | Predictive Oncology Inc. | Other | $173,274,405 | $173,274,405 | 20 | 1 |
| 2025-10-22 | Predictive Oncology Inc. | Other | $50,769,628 | $50,769,628 | 29 | 1 |
| 2025-09-08 | Predictive Oncology Inc. | Biotechnology | $413,093 | $413,093 | 1 | 1 |
| 2024-08-02 | Predictive Oncology Inc. | Biotechnology | $2,161,032 | $2,161,032 | 8 | 1 |
| 2022-06-02 | Predictive Oncology Inc. | Biotechnology | $2,302,368 | $2,302,368 | 4 | 2 |
| 2021-03-18 | Predictive Oncology Inc. | Biotechnology | $17,635,343 | $17,635,343 | 19 | 1 |
| 2021-02-02 | Predictive Oncology Inc. | Biotechnology | $16,760,975 | $16,760,975 | 10 | 2 |
| 2020-07-10 | Predictive Oncology Inc. | Biotechnology | $1,750,000 | $1,750,000 | 18 | 1 |
| 2020-03-30 | Predictive Oncology Inc. | Other Health Care | $3,500,000 | $3,500,000 | 2 | 1 |
| 2019-07-29 | Predictive Oncology Inc. | Other Health Care | $3,500,000 | $1,139,000 | 11 | 1 |
| 2018-10-11 | Precision Therapeutics Inc. | Other Health Care | $2,500,000 | $2,000,000 | 2 | 1 |
| 2017-12-12 | Skyline Medical Inc. | Other Health Care | $1,300,000 | $1,300,000 | 1 | 1 |
| 2014-08-06 | Skyline Medical Inc. | Other Health Care | $977,565 | $122,196 | 1 | 1 |
| 2014-07-24 | Skyline Medical Inc. | Other Health Care | $733,174 | $733,174 | 2 | 1 |
| 2014-02-05 | Skyline Medical Inc. | Manufacturing | $2,055,000 | $2,055,000 | 16 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Predictive Oncology Inc. | PA | Form D private offerings | CIK (EXACT) |
| SEC filer | Axe Compute Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | SKYLINE MEDICAL INC. | State business registries | EIN (EXACT, as the state registration reports it) | |
| Form 5500 plan sponsor | AXE COMPUTE INC | EIN (EXACT) | ||
| Person page | Arnon I Dreyfuss | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | J Melville Engle | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other) | |
| Person page | Kevin R Davidson | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Finance Services, FL first:
- MGT CAPITAL INVESTMENTS, INC. FL
- STERLING FINANCIAL SERVICES OF FLORIDA I INC FL
- Athena Bitcoin Global FL
- SBS FUNDING INC FL
- Tron Inc. FL
- OpenWorld, Inc. FL
- NextPlay Technologies Inc. FL
- Stablecoin Development Corp FL
- T-REX Acquisition Corp. FL
- MARA Holdings, Inc. FL
In other datasets, the same topic (Finance) in FL:
- Form D issuer: Aeterna Opes NH Fund I LP (Form D private offerings)
- Lobbying client: 777 PARTNERS LLC (Federal lobbying (LDA))
Interests: Finance Services · Finance